Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Annals of hematology - 101(2022), 9 vom: 12. Sept., Seite 2119-2121 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Yifei [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 16.08.2022 Date Revised 19.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00277-022-04890-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343417146 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343417146 | ||
| 003 | DE-627 | ||
| 005 | 20231226020411.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00277-022-04890-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1144.xml |
| 035 | |a (DE-627)NLM343417146 | ||
| 035 | |a (NLM)35821344 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Yifei |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.08.2022 | ||
| 500 | |a Date Revised 19.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a belantamab mafodotin |2 NLM | |
| 650 | 7 | |a DB1041CXDG |2 NLM | |
| 700 | 1 | |a Godara, Amandeep |e verfasserin |4 aut | |
| 700 | 1 | |a Pan, Stacey |e verfasserin |4 aut | |
| 700 | 1 | |a Toskic, Denis |e verfasserin |4 aut | |
| 700 | 1 | |a Mann, Hashim |e verfasserin |4 aut | |
| 700 | 1 | |a Sborov, Douglas |e verfasserin |4 aut | |
| 700 | 1 | |a Comenzo, Raymond |e verfasserin |4 aut | |
| 700 | 1 | |a Kansagra, Ankit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d 1991 |g 101(2022), 9 vom: 12. Sept., Seite 2119-2121 |w (DE-627)NLM012918768 |x 1432-0584 |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2022 |g number:9 |g day:12 |g month:09 |g pages:2119-2121 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00277-022-04890-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2022 |e 9 |b 12 |c 09 |h 2119-2121 | ||